humble 2007 vitamin d review complete references
TRANSCRIPT
Complete references to:
Mats Humble: D-vitaminbrist kanske vanligare än vi trott. Prevention och behandling skulle kunna
ge oanade folkhälsoeffekter.
Läkartidningen 2007, vol 104, nr 11, sid 853-7.
Referenser:
1. Gloth FM 3rd, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of
seasonal affective disorder. J Nutr Health Aging. 1999;3(1):5-7.
2. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin
Nutr. 1999;69(5):842-56.
3. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr.
2003;89(5):552-72.
4. Heaney RP. Long-latency deficiency disease: insights from calcium and vitamin D. Am J Clin Nutr.
2003;78(5):912-9.
5. Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur
J Clin Invest. 2005;35(5):290-304.
6. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease,
and osteoporosis. Am J Clin Nutr. 2004;79:362-71.
7. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of
vitamin D3: Exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3
synthesis in human skin. J Clin Endocrinol Metab. 1988;67:373-8.
8. Webb AR, Engelsen O. Calculated Ultraviolet Exposure Levels for a Healthy Vitamin D Status.
Photochem Photobiol. 2006 Sep 1; [Epub ahead of print], doi: 10.1562/2005-09-01-RA-670.
9. Burleigh E, Potter J. Vitamin D deficiency in outpatients: a Scottish perspective. Scott Med J.
2006;51(2):27-31.
10. McLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J
Clin Invest. 1985;76:1536-8.
11. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol. 2005;62:265-81.
12. Clemens TL, Adams JS, Henderson SL, Holick MF. Increased skin pigment reduces the capacity of
skin to synthesise vitamin D3. Lancet. 1982;1:74-76.
13. Zenkert-Andersson K, Hedeland H, Manhem P. För lite sol kan ge D-vitaminbrist: Muslimska
kvinnor i Sverige är en riskgrupp. Läkartidningen. 1996;93:4153-5.
14. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thomsen J, Charles P, Eriksen EF.
Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited.
J Intern Med. 2000;247:260-8.
15. Holvik K, Meyer HE, Haug E, Brunvand L. Prevalence and predictors of vitamin D deficiency in five
immigrant groups living in Oslo, Norway: the Oslo Immigrant Health Study. Eur J Clin Nutr.
2005;59(1):57-63.
16. Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M, Soltani A, Shafaei AR, Hamidi
Z, Fard AR, Hossein-Nezhad A, Booya F. Vitamin D deficiency and causative factors in the
population of Tehran. BMC Public Health. 2004;4:38.
17. Al Faraj S, Al Mutairi K. Vitamin D Deficiency and chronic low back pain in Saudi Arabia. Spine
2003;28(2):177-9.
18. European Commission: Health & Consumer Protection Directorate-General. Opinion of the
scientific committee on food on the tolerable upper intake level of vitamin D. 2002 Dec 16 [cited
2006 Jan 14, 35 p.] Available from: www.europa.eu.int/comm/food/fs/sc/scf/out80_en.html.
19. Steingrimsdottír L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G. Relationship between
serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA.
2005;294(18):2336-41.
20. Becker W, Pearson M. Riksmaten 1997-98. Befolkningens kostvanor och näringsintag. Uppsala:
Livsmedelsverket; 2002.
21. Livsmedelsverkets livsmedelsdatabas, version 04.1.1.
22. Outila TA, Mattila PH, Piironen VI, Lamberg-Allardt CJ. Bioavailability of vitamin D from wild
edible mushrooms (Cantharellus tubaeformis) as measured with a human bioassay. Am J Clin
Nutr. 1999;69(1):95-8.
23. Rejnmark L, Jørgensen ME, Pedersen MB, Hansen JC, Heickendorff L, Lauridsen AL, Mulvad G,
Siggaard C, Skjoldborg H, Sørensen TB, Pedersen EB, Mosekilde L. Vitamin D insufficiency in
Greenlanders on a westernized fare: Ethnic differences in calcitropic hormones between
Greenlanders and Danes. Calcif Tissue Int. 2004;74:255-63.
24. Reinhardt TA, Ramberg CF, Horst RL. Comparison of receptor binding, biological activity, and in
vivo tracer kinetics for 1,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D2, and its 24 epimer.
Arch Biochem Biophys. 1989;273(1):64-71.
25. Tjellesen L, Hummer L, Christiansen C, Rødbro P. Serum concentration of vitamin D metabolites
during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner.
1986;1:407-13.
26. Armas LAG, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J
Clin Endocrinol Metab. 2004;89(11):5387-91.
27. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D.
[Review] Physiol Rev. 1998;78(4):1193-231.
28. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Invited review. Am J Physiol Renal Physiol.
2005;289:F8-F28.
29. Lehmann B. The vitamin D3 pathway in human skin and its role for regulation of biological
processes. Photochem Photobiol. 2005;81(6):1246-51.
30. Drezner MK. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav. 2004;5
Suppl 2:S41-7.
31. Burgner D, Schölvinck E, Coren M, Walters S. Chalk and cheese: symptomatic hypocalcaemia
during paediatric anti-tuberculous therapy. J Infection. 2004;49:169-71.
32. Ogunkolade WB, Boucher BJ, Bustin SA, Burrin JM, Noonan K, Mannan N, Hitman GA. Vitamin D
metabolism in peripheral blood mononuclear cells is influenced by chewing 'Betel nut' (Areca
catechu) and vitamin D status. J Clin Endocrin Metab. 2006: doi:10.1210/jc.2005-2750.
33. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia.
2005;48:1247-57.
34. Oren DA, Schulkin J, Rosenthal NE. 1,25(OH)2 vitamin D3 levels in seasonal affective disorder:
effects of light. Psycho¬pharmacology (Berl). 1994;116(4):515-6.
35. Carlberg C. Current understanding of the function of the nuclear vitamin D receptor in response
to its natural and synthetic ligands. Recent Results Cancer Res. 2003;164:29-42.
36. Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S, Rastad J, Åkerström G, Melhus H.
Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med. 1995;1(12):1309-11
37. Lorentzon M, Lorentzon R, Nordström P. Vitamin D receptor gene polymorphism is associated
with birth height, growth to adolescence, and adult stature in healthy caucasian men: a cross-
sectional and longitudinal study. J Clin Endocrinol Metab. 2000;85(4):1666-70
38. Grundberg E, Brändström H, Ribom EL, Ljunggren Ö, Mallmin H, Kindmark A. Genetic variation in
the human vitamin D receptor is associated with muscle strength, fat mass and body weight in
Swedish women. Eur J Endocrinol. 2004;150(3):323-8.
39. Remes T, Väisänen SB, Mahonen A, Huuskonen J, Kröger H, Jurvelin JS, Rauramaa R. Bone mineral
density, body height, and vitamin D receptor gene polymorphism in middle-aged men. Ann Med.
2005;37(5):383-92.
40. Norman AW, Okamura WH, Bishop JE, Henry HL. Update on biological actions of 1alpha,25(OH)2-
vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3. Mol Cell Endocrinol. 2002;197(1-2):1-13.
41. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for
bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477-501.
42. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture
prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials.
JAMA 2005;293:2257-64.
43. Boonen S, Vanderschueren D, Haentjens P, Lips P. Calcium and vitamin D in the prevention and
treatment of osteoporosis - a clinical update. J Intern Med. 2006;259:539-52.
44. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-
hydroxy vitamin D levels and bone mineral density: a population-based study of younger and
older adults. Am J Med. 2004;116(9):634-9.
45. Välimäki VV, Alfthan H, Lehmuskallio E, Löyttyniemi E, Sahi T, Stenman UH, Suominen H, Välimäki
MJ. Vitamin D status as a determinant of peak bone mass in young Finnish men. J Clin Endocrinol
Metab. 2004;89(1):76-80.
46. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range
for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003;22(2):142-6.
47. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal
vitamin D status. Osteoporos Int. 2005;16:713-6.
48. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006;92(1):4-8.
49. Vieth R, Ladak Y, Walfish PG. Age-related changes in the 25-hydroxyvitamin D versus parathyroid
hormone relationship suggest a different reason why older adults require more vitamin D. J Clin
Endocrinol Metab 2003;88:185-91.
50. Sahota O, Mundey MK, San P, Godber IM, Hosking DJ. Vitamin D insufficiency and the blunted
PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int.
2006;17(7):1013-21.
51. Nordin BE, Baker MR, Horsman A, Peacock M. A prospective trial of the effect of vitamin D
supplementation on metacarpal bone loss in elderly women. Am J Clin Nutr. 1985;42(3):470-4.
52. Allain TJ, Kirthisingha V, Beresford PA, Bell NJ. Use of vitamin D supplements and vitamin D status
in patients taking bisphosphonate drugs. Rheumatology (Oxford). 2006;45(4):486-7.
53. McAlindon TE, Felson DT, Zhang Y, Hannan MT, Aliabadi P, Weissman B, Rush D, Wilson PW,
Jacques P. Relation of dietary intake and serum levels of vitamin D to progression of
osteoarthritis of the knee among participants in the Framingham Study. Ann Intern Med.
1996;125(5):353-9.
54. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong
JB. Effect of Vitamin D on falls: a meta-analysis. JAMA. 2004;291(16):1999-2006.
55. Sörensen OH, Lund B, Saltin B, Lund B, Andersen RB, Hjorth L, Melsen F, Mosekilde L. Myopathy
in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and
calcium. Clin Sci (Lond). 1979;56(2):157-61.
56. Sato Y, Iwamoto J, Kanoko T, Satoh K. Low-dose vitamin D prevents muscular atrophy and
reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc
Dis. 2005;20(3):187-92.
57. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, Charles P, Eriksen EF.
Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif
Tissue Int. 2000;66(6):419-24.
58. Visser M, Deeg DJH, Lips P. Low vitamin D and high parathyroid hormone levels as determinants
of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study
Amsterdam. J Clin Endocrinol Metab. 2003;88(12):5766-5772.
59. Dhesi JK, Jackson SH, Bearne LM, Moniz C, Hurley MV, Swift CG, Allain TJ. Vitamin D
supplementation improves neuromuscular function in older people who fall. Age Ageing.
2004;33(6):589-95.
60. Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an authentic
strength preserving hormone. Molec Asp Med. 2005;26:203-19.
61. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. The Role of
Vitamin D in Cancer Prevention. Am J Public Health. 2006;96(2):252-61.
62. Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of
solar ultraviolet-B radiation. Cancer. 2002;94(6):1867-75.
63. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E,
Wei M, Holick MF. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol.
2005;97(1-2):179-94.
64. Smedby KE, Hjalgrim H, Melbye M, Torrang A, Rostgaard K, Munksgaard L, Adami J, Hansen M,
Porwit-MacDonald A, Jensen BA, Roos G, Pedersen BB, Sundström C, Glimelius B, Adami HO.
Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst.
2005;97(3):199-209.
65. Naveilhan P, Berger F, Haddad K, Barbot N, Benabid AL, Brachet P, Wion D. Induction of glioma
cell death by 1,25(OH)2 vitamin D3: towards an endocrine therapy of brain tumors? J Neurosci
Res. 1994;37(2):271-7.
66. Trouillas P, Honnorat J, Bret P, Jouvet A, Gerard JP. Redifferentiation therapy in brain tumors:
long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term
1-alpha-hydroxychole¬calciferol. J Neurooncol. 2001;51(1):57-66.
67. Woo TC, Choo R, Jamieson M, Chander S, Vieth R. Pilot study: potential role of vitamin D
(Cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr Cancer.
2005;51(1):32-6.
68. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al., for
the Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk
of colorectal cancer. N Engl J Med. 2006;354(7):684-96.
69. Reichrath J. The challenge resulting from positive and negative effects of sunlight: how much
solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin
cancer? Prog Biophys Mol Biol. 2006;92(1):9-16.
70. Lind L, Wengle B, Ljunghall S. Blood pressure is lowered by vitamin D (alphacalcidol) during long-
term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled
study. Acta Med Scand. 1987;222(5):423-7.
71. Lind L, Wengle B, Wide L, Ljunghall S. Reduction of blood pressure during long-term treatment
with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A
double-blind, placebo-controlled study. Am J Hypertens. 1989;2(1):20-5.
72. Lind L, Hänni A, Lithell H, Hvarfner A, Sörensen OH, Ljunghall S. Vitamin D is related to blood
pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens.
1995;8(9):894-901.
73. Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising
syndrome 'X'? Br J Nutr. 1998;79(4):315-27.
74. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency
into perspective. [Review] Br J Nutr. 2005;94(4):483-92.
75. Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, Reeve J, Warburton EA. Reduced vitamin D in
acute stroke. Stroke. 2006;37(1):243-5.
76. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta
cell dysfunction. Am J Clin Nutr. 2004;79(5):820-5.
77. Hyppönen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort.
Diabetes Care. 2006;29(10):2244-6.
78. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator
of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004;89-90(1-
5):387-92.
79. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, Aganna E, Price
CP, Boucher BJ. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR
genotype: mechanisms for inflammatory damage in chronic disorders? QJM. 2002;95(12):787-96.
80. Auwerx J, Bouillon R, Kesteloot H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-I,
and high density lipoprotein cholesterol. Arterioscler Thromb. 1992;12(6):671-4.
81. John WG, Noonan K, Mannan N, Boucher BJ. Hypovitaminosis D is associated with reductions in
serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis. Am J Clin Nutr.
2005;82(3):517-22.
82. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type
1 diabetes: a birth-cohort study. Lancet. 2001;358:1500-3.
83. Helming L, Böse J, Ehrchen J, Scheibe S, Frahm T, Geffers R, Probst-Kepper M, Balling R, Lengeling
A. 1±,25-dihydroxyvitamin D3 is a potent suppressor of interferon Ž-mediated macrophage
activation. Blood. 2005;106(13):4351-8.
84. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D
supplementation improves cytokine profiles in patients with congestive heart failure: a double-
blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83(4):754-9.
85. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting
autoimmune disease prevalence. Exp Biol Med (Maywood). 2004;229(11):1136-42.
86. VanAmerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update.
Eur J Clin Nutr. 2004;58(8):1095-109.
87. Brohult J, Jonson B. Effects of large doses of calciferol on patients with rheumatoid arthritis. A
double-blind clinical trial. Scand J Rheumatol. 1973;2(4):173-6.
88. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C,
Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis
BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human
antimicrobial response. Science. 2006;311(5768):1770-3.
89. Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN. Prevalence and associations of
vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect.
2005;50(5):432-7.
90. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E.
Epidemic influenza and vitamin D. Epidemiol Infect. 2006, doi:10.1017/S0950268806007175.
91. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in
patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones.
2006;38(1):3-5.
92. Dietrich T, Joshipura KJ, Dawson-Hughes B, Bischoff-Ferrari HA. Association between serum
concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. Am J Clin
Nutr. 2004;80(1):108-13.
93. Dietrich T, Nunn M, Dawson-Hughes B, Bischoff-Ferrari HA. Association between serum
concentrations of 25-hydroxyvitamin D and gingival inflammation. Am J Clin Nutr.
2005;82(3):575-80.
94. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D
functions in the nervous system. Trends Endocrinol Metab. 2002;13(3):100-5.
95. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and
1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21-30.
96. McGrath JJ, Feron FP, Burne TH, Mackay-Sim A, Eyles DW. Vitamin D3-implications for brain
development. [Review] J Steroid Biochem Mol Biol. 2004;89-90(1-5):557-60.
97. Kalueff AV, Eremin KO, Tuohimaa P. Mechanisms of neuroprotective action of vitamin D3.
Biochemistry (Mosc). 2004;69(7):738-41.
98. Tetich M, Kutner A, Leskiewicz M, Budziszewska B, Lason W. Neuroprotective effects of (24R)-
1,24-dihydroxycholecalciferol in human neuroblastoma SH-SY5Y cell line. J Steroid Biochem Mol
Biol. 2004;89-90(1-5):365-70.
99. Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter.
Psychopharmacology (Berl). 1998;135(4):319-23.
100. Vieth R, Kimball S, Hu A, Walfish PG. Randomized comparison of the effects of the vitamin D3
adequate intake versus 100 ºg (4000 IU) per day on biochemical responses and the wellbeing of
patients. Nutr J. 2004;3(1):8. doi:10.1186/1475-2891-3-8.
101. Robbins J, Hirsch C, Whitmer R, Cauley J, Harris T. The association of bone mineral density and
depression in an older population. J Am Geriatr Soc. 2001;49(6):732-6.
102. Mussolino ME. Depression and hip fracture risk: the NHANES I epidemiologic follow-up study.
Public Health Rep. 2005;120(1):71-5.
103. Hummer M, Malik P, Gasser RW, Hofer A, Kemmler G, Moncayo Naveda RC, Rettenbacher MA,
Fleischhacker WW. Osteoporosis in patients with schizophrenia. Am J Psychiatry.
2005;162(1):162-7.
104. Kishimoto T, Watanabe K, Takeuchi H, Kikuchi T, Nakajima S, Shimada N, Yagi G, Kashima H.
Bone mineral density measurement in female inpatients with schizophrenia. Schizophr Res.
2005;77(1):113-5.
105. Holmberg AH, Johnell O, Nilsson PM, Nilsson J, Berglund G, Åkesson K. Risk factors for
fragility fracture in middle age. A prospective population-based study of 33,000 men and women.
Osteoporos Int. 2006;17(7):1065-77.
106. Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J. Neuropsychological function in
relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels The Tromsø study.
J Neurol. 2006;243(4):464-70.
107. McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, Jarvelin MR, Chant D, Isohanni M.
Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth
cohort study. Schizophr Res. 2004;67(2-3):237-45.
108. Feron F, Burne TH, Brown J, Smith E, McGrath JJ, Mackay-Sim A, Eyles DW.
Developmental vitamin D3 deficiency alters the adult rat brain. Brain Res Bull. 2005;65(2):141-8.
109. Howard DA, Waygood S, Desmond S. Vitamin D and chronic mental illness. Med J Aust.
2006;184(1):47.
110. Johansson C, Black D, Johnell O, Oden A, Mellström D. Bone mineral density is a
predictor of survival. Calcif Tissue Int. 1998;63(3):190-6.
111. Visser M, Deeg DJ, Puts MT, Seidell JC, Lips P. Low serum concentrations of 25-
hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr. 2006
Sep;84(3):616-22.
112. Oliveri B, Plantalech L, Bagur A, Wittich AC, Rovai G, Pusiol E, Lopez Giovanelli J, Ponce
G, Nieva A, Chaperon A, Ladizesky M, Somoza J, Casco C, Zeni S, Parisi MS, Mautalen CA. High
prevalence of vitamin D insufficiency in healthy elderly people living at home in Argentina. Eur J
Clin Nutr. 2004;58(2):337-42.
113. Landin-Wilhelmsen K, Wilhelmsen L, Wilske J, Lappas G, Rosén T, Lindstedt G, Lundberg PA, Bengtsson BÅ. Sunlight increases serum 25(OH) vitamin D concentration whereas 1,25(OH)2D3 is unaffected. Results from a general population study in Göteborg, Sweden (The WHO MONICA Project). Eur J Clin Nutr. 1995;49(6):400-7.
114. Brot C, Vestergaard P, Kolthoff N, Gram J, Hermann AP, Sørensen OH. Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr. 2001;86 Suppl 1:S97-103.
115. Larsson CL, Johansson GK. Dietary intake and nutritional status of young vegans and omnivores in Sweden. Am J Clin Nutr. 2002;76(1):100-6.
116. Basha B, Rao DS, Han ZH, Parfitt AM. Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. Am J Med. 2000;108(4):296-300.
117. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72(3):690-3.
118. Snijder MB, van Dam RM, Visser M, Deeg DJH, Dekker JM et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005;90(7):4119-23.
119. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1):18-28.
120. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998;351:805-6.
121. Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest. 1996;109(2):535-9. 122. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-
hydroxycholecalci¬ferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77(1):204-10. Erratum in: Am J Clin Nutr. 2003;78(5):1047.
123. Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73(2):288-94.
124. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326(7387):469.
125. Heikinheimo RJ, Inkovaara JA, Harju EJ, Haavisto MV, Kaarela RH, Kataja JM, Kokko AM, Kolho LA, Rajala SA. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int. 1992;51(2):105-10.
126. Mastaglia SR, Mautalen CA, Parisi MS, Oliveri B. Vitamin D(2) dose required to rapidly increase 25OHD levels in osteoporotic women. Eur J Clin Nutr. 2006;60(5):681-7.
127. Grimes DS. Are statins analogues of vitamin D? Lancet. 2006;368:83-86. 128. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, et al., for the
Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669-83.
129. Wu-Wong JR, Tian J, Goltzman D. Vitamin D analogs as therapeutic agents: a clinical study update. Curr Opin Investig Drugs. 2004;5(3):320-6.